top of page
shutterstock_128839060.jpg

Prena's Mission:

​

Safeguarding infants by reducing the number of tragedies associated with preterm birth

shutterstock_69363076.jpg
shutterstock_35907118.jpg
shutterstock_190748117.jpg

“Preventing preterm birth is a huge medical priority and a significant unmet need.

​

Prena's new approach to switching off contractions of the womb is very exciting and promises to deliver a non-invasive way to treat preterm labour”

​

               Professor Anna David, PhD MRCOG MB 

                  Head of  Department of Maternal Fetal Medicine

                                    Institute for Women's Health, University College London

SCIENCE

Prena is creating a safe non-invasive photo biomodulation approach to stopping and preventing preterm contractions.

​

The hormone Melatonin, which regulates our circadian clock, acts upon receptors that form in the uterus immediately preceding labor. That interaction causes smooth muscle contractions . . . labor.

 

In human testing using light to down-regulate Melatonin the Company  achieved over a 70% success in stopping or reducing contractions to a safe level.

INVESTORS

Prena is now poised to finish the development and clinical testing of  this product:

a sleep mask that emits a very low intensity cerulean light that passes through the sleeping woman's eyelids and communicates with the pineal gland to  down regulate melatonin's secretion.

 

The product is 95% complete. The manufacturer and cost has been locked down.  

 

The clinical plan is advancing, Sites have been Selected for the pivotal clinical trials,

​

To date approximately 75% of the company's funding has come from two institutional investors.

NEWS

Here you will find recent news from the Company, including:

​

  • Prena named one of the top solution providers in Gynecology by MedTech 9/20

​

  • Prena enlists two world 

​       renowned  Clinicians to            serve on Prena's Clinical            Advisory Board. 6/20

​

  • Doctor James Olcese collaborated with researchers at Brigham and Women’s Hospital on an NIH funded study which validated KynderMed's (Prena) Science. The results were published in 12/ 2019

​

​

​

 

ABOUT US

Prena is  leveraging new scientific understandings to reduce the incidence of preterm birth.

​

Prena's team is comprised of globally recognized scientists and clinical experts that are recognized as thought leaders in perinatal care and obstetrics / gynecology,  as well as senior business executives ...  all with a driving mission to reduce the tragedies resulting from preterm birth. 

"For far too long this area has been an innovation wasteland"

​

                 Julian Robinson, MD

                 Chief of Obstetrics

                       Brigham and Womens Hospital

                        

Prena's simple and safe solution to move out of the "wasteland" and address this tragic unmet medical need:

Brille 1.png
Maskaway.png

A comfortable sleep mask that emits a soft, non- disruptive cerulean blue light through the eyelids of the sleeping mother.

​

In most cases will be sufficient to prevent the onset of labour.

Prena-Biz-Card - Kopie2.jpg

Statements on this website have not been evaluated by the Food and Drug Administration

bottom of page